Back to Search
ALICE GOTTLIEB, M.D.
M.D.
Dermatology Physician
NPI: 1275581407Individual
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
227191(MA)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.
PMID 29614243·J Am Acad Dermatol·2018
3-trial
Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
PMID 30124724·J Drugs Dermatol·2018
8-other
Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
PMID 27707593·J Am Acad Dermatol·2017
3-trial
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.
PMID 27113059·Am J Clin Dermatol·2016
6-review
CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial.
PMID 25946554·JAMA Dermatol·2015
4-observational
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
PMID 18047523·Br J Dermatol·2008
4-observational
Mechanisms of action of etanercept in psoriasis.
PMID 17502868·J Investig Dermatol Symp Proc·2007
6-review
Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients.
PMID 17010737·J Am Acad Dermatol·2006
8-other
Induction of lesional and circulating leukocyte apoptosis by infliximab in a patient with moderate to severe psoriasis.
PMID 17039656·J Drugs Dermatol·2006
5-case
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
PMID 16081850·J Immunol·2005
8-other
Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
PMID 15955104·J Invest Dermatol·2005
3-trial
Manifestations of cutaneous sarcoidosis: a case report of an African American woman.
PMID 19585935·J Natl Med Assoc·2009
5-case
Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists.
PMID 19539844·J Am Acad Dermatol·2009
5-case
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.
PMID 19217154·Lancet·2009
4-observational
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
PMID 19217694·J Am Acad Dermatol·2009
6-review
Common peptides shed light on evolution of Olfactory Receptors.
PMID 19416542·BMC Evol Biol·2009
7-preclinical
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
PMID 19493586·J Am Acad Dermatol·2009
8-other
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
PMID 19527820·J Am Acad Dermatol·2009
8-other
Defects in ErbB-dependent establishment of adult melanocyte stem cells reveal independent origins for embryonic and regeneration melanocytes.
PMID 19578401·PLoS Genet·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 969 MAIN ST STE D
FISHKILL, NY 12524 - Phone
- (845) 896-7730
Quick Facts
- NPI
- 1275581407
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 3
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile